A promising new treatment developed in northeast Ohio is offering new hope for people with spinal cord injuries.
WOIO reports a drug called NVG-291, developed at Case Western Reserve University’s biotechnology incubator, is showing significant results in clinical trials.
Researchers say the drug works by helping damaged nerves regenerate, something long considered one of the biggest barriers in treating paralysis.
In one case, a woman who was paralyzed from the neck down regained movement in her hands within weeks and is now able to walk short distances.
Scientists say the results are unprecedented, and larger trials are expected as the drug moves closer to potential FDA approval.
Experts also believe the treatment could eventually help patients with other neurological conditions, including Alzheimer’s and Parkinson’s disease.
